Therefore, PIKFYVE inhibitors, either alone or in combination with other targeted drugs or genetic manipulation (including ectopic IL24 protein), exhibit significant in vitro regression of growth of PIKFYVE-sensitive cancers. Here, PIKFYVE is linked to cancer.